Sunnie S. Kim

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

University of Colorado Anschutz Medical Campus(Current)

Sunnie S. Kim is an author at University of Colorado Anschutz Medical Campus specializing in immunotherapy, monoclonal antibodies in oncology, and bispecific antibody therapy.

ORCID

Publications per year

2023–2025

Publications

A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors

Geoffrey Y. Ku, Lin Shen, Farshid Dayyani et al. · Clinical Cancer Research · 2025 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17

First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors

Anna Schreiber, Jodi Kagihara, Bradley R. Corr et al. · Cancers · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +15

1–2 of 2